NO20031958D0 - Farmasöytisk dronedaron-preparat for parenteral administrering - Google Patents

Farmasöytisk dronedaron-preparat for parenteral administrering

Info

Publication number
NO20031958D0
NO20031958D0 NO20031958A NO20031958A NO20031958D0 NO 20031958 D0 NO20031958 D0 NO 20031958D0 NO 20031958 A NO20031958 A NO 20031958A NO 20031958 A NO20031958 A NO 20031958A NO 20031958 D0 NO20031958 D0 NO 20031958D0
Authority
NO
Norway
Prior art keywords
dronedarone
pharmaceutical
preparation
parenteral administration
parenteral
Prior art date
Application number
NO20031958A
Other languages
English (en)
Other versions
NO20031958L (no
NO332294B1 (no
Inventor
Frederique Bourriague-Seve
Thierry Breul
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20031958D0 publication Critical patent/NO20031958D0/no
Publication of NO20031958L publication Critical patent/NO20031958L/no
Publication of NO332294B1 publication Critical patent/NO332294B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
NO20031958A 2000-12-11 2003-04-29 Farmasoytisk dronedaron-preparat for parenteral administrering NO332294B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0016071A FR2817750B1 (fr) 2000-12-11 2000-12-11 Composition pharmaceutique de dronedarone pour administration parenterale
PCT/FR2001/003903 WO2002047660A1 (fr) 2000-12-11 2001-12-10 Composition pharmaceutique de dronedarone pour administration parenterale

Publications (3)

Publication Number Publication Date
NO20031958D0 true NO20031958D0 (no) 2003-04-29
NO20031958L NO20031958L (no) 2003-06-11
NO332294B1 NO332294B1 (no) 2012-08-20

Family

ID=8857483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031958A NO332294B1 (no) 2000-12-11 2003-04-29 Farmasoytisk dronedaron-preparat for parenteral administrering

Country Status (31)

Country Link
US (1) US6939865B2 (no)
EP (1) EP1343473B1 (no)
JP (1) JP4399161B2 (no)
KR (1) KR100849758B1 (no)
CN (1) CN1235566C (no)
AR (1) AR031649A1 (no)
AT (1) ATE348599T1 (no)
AU (2) AU1722902A (no)
BG (1) BG66187B1 (no)
BR (1) BR0116060B1 (no)
CA (1) CA2427375C (no)
CZ (1) CZ297788B6 (no)
DE (1) DE60125411T2 (no)
EA (1) EA005314B1 (no)
FR (1) FR2817750B1 (no)
HK (1) HK1055906A1 (no)
HU (1) HU229372B1 (no)
IL (2) IL155428A0 (no)
IS (1) IS2349B (no)
MA (1) MA26969A1 (no)
ME (2) ME00083B (no)
MX (1) MXPA03005221A (no)
NO (1) NO332294B1 (no)
NZ (1) NZ525661A (no)
OA (1) OA12416A (no)
PL (1) PL199846B1 (no)
RS (1) RS50348B (no)
SK (1) SK287115B6 (no)
TW (1) TWI246926B (no)
WO (1) WO2002047660A1 (no)
ZA (1) ZA200303406B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800177A (en) * 2006-02-14 2008-01-01 Wyeth Corp Aqueous pharmaceutical formulations of ERβ selective ligands
GB0719180D0 (en) * 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
AR072950A1 (es) 2008-04-17 2010-10-06 Sanofi Aventis Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad, composicion farmaceutica, articulo de fabricacion y envase
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
FR2959132A1 (fr) * 2010-04-22 2011-10-28 Sanofi Aventis Procedes pour l'evaluation et la reduction des risques
TWI508726B (zh) 2009-12-21 2015-11-21 Gilead Sciences Inc 治療心房纖維性顫動之方法
US20120005128A1 (en) * 2010-06-29 2012-01-05 Sanofi Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
CN102342907A (zh) 2010-07-30 2012-02-08 江苏恒瑞医药股份有限公司 决奈达隆固体分散体及其制备方法
KR20120094557A (ko) * 2011-02-01 2012-08-27 동아제약주식회사 피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제
CN102908307A (zh) * 2011-08-03 2013-02-06 天津市嵩锐医药科技有限公司 供注射用盐酸决奈达隆药物组合物及其制备方法
MA37753B1 (fr) * 2012-07-12 2019-04-30 Sanofi Sa Composition antitumorale comprenant le composé 1-(6-{[6-(4-fluorophényl)[1,2,4]triazolo[4,3-b] pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-yléthyl)urée
CN114377148B (zh) * 2020-10-20 2023-09-29 上海博志研新药物研究有限公司 盐酸决奈达隆药物组合物、其制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2746013B1 (fr) * 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
JP2004327321A (ja) * 2003-04-25 2004-11-18 Jst Mfg Co Ltd コネクタ

Also Published As

Publication number Publication date
BG66187B1 (bg) 2011-12-30
BR0116060A (pt) 2004-03-02
CN1235566C (zh) 2006-01-11
EP1343473B1 (fr) 2006-12-20
RS50348B (sr) 2009-11-10
CZ297788B6 (cs) 2007-03-28
MA26969A1 (fr) 2004-12-20
NZ525661A (en) 2004-11-26
EP1343473A1 (fr) 2003-09-17
KR100849758B1 (ko) 2008-07-31
EA005314B1 (ru) 2004-12-30
EA200300406A1 (ru) 2003-10-30
IL155428A0 (en) 2003-11-23
CA2427375A1 (fr) 2002-06-20
DE60125411T2 (de) 2007-10-11
KR20030060985A (ko) 2003-07-16
SK7262003A3 (en) 2004-02-03
NO20031958L (no) 2003-06-11
AU1722902A (en) 2002-06-24
SK287115B6 (sk) 2009-12-07
PL362788A1 (en) 2004-11-02
AU2002217229B2 (en) 2006-05-18
CN1479610A (zh) 2004-03-03
WO2002047660A1 (fr) 2002-06-20
US20040044070A1 (en) 2004-03-04
CA2427375C (fr) 2011-02-01
IS6801A (is) 2003-04-30
PL199846B1 (pl) 2008-11-28
NO332294B1 (no) 2012-08-20
US6939865B2 (en) 2005-09-06
DE60125411D1 (de) 2007-02-01
BR0116060B1 (pt) 2013-12-31
MEP20408A (en) 2010-06-10
JP2004528277A (ja) 2004-09-16
HUP0500842A2 (hu) 2005-12-28
OA12416A (fr) 2006-04-18
HK1055906A1 (en) 2004-01-30
YU46503A (sh) 2006-08-17
FR2817750B1 (fr) 2003-02-21
AR031649A1 (es) 2003-09-24
ZA200303406B (en) 2004-05-03
ATE348599T1 (de) 2007-01-15
IS2349B (is) 2008-04-15
TWI246926B (en) 2006-01-11
HU229372B1 (en) 2013-11-28
FR2817750A1 (fr) 2002-06-14
CZ20031612A3 (cs) 2003-09-17
MXPA03005221A (es) 2004-03-26
IL155428A (en) 2007-10-31
BG107748A (bg) 2004-03-31
ME00083B (me) 2010-10-10
JP4399161B2 (ja) 2010-01-13

Similar Documents

Publication Publication Date Title
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
NO20071303L (no) Farmasoytiske preparater
EE05376B1 (et) Vesisuspensioonip?hineÁparenteraalneÁravimpreparaatÁjaÁsedaÁsisaldavÁviaal
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
ITTO20010008A0 (it) Formulazione farmaceutica
NO20030418D0 (no) Nytt farmasöytisk preparat
NO20020976D0 (no) Retarderte, orale, farmasöytiske administreringsformer
DE60142197D1 (de) Pharmazeutische Zusammensetzung
DK1399127T3 (da) Olopatadinformuleringer til topisk administration
DE60126089D1 (de) Verabreichungssystem
DK1466615T3 (da) Farmaceutisk præparat
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20031958D0 (no) Farmasöytisk dronedaron-preparat for parenteral administrering
NO20014738L (no) Tolperisonholdig farmasöytisk preparat for oral administrering
AU2002217229A1 (en) Pharmaceutical dronedarone composition for parenteral administration
ATE366128T1 (de) Pharmazeutische zusammensetzung
IS6163A (is) Lyfjakomplex
NO20032957D0 (no) Farmasöytisk emulsjonspreparat
NO20021036D0 (no) Farmasöytisk preparat
SE0004677D0 (sv) Intraaxonal läkemedelsadministration

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees